Search Reports

Showing search results for "All"

Below you can search for shortage and discontinuation reports that have been submitted for drug products by a company.

For more information on how to search reports, see “How to Search” section in the Website overview for public users, found in the About & Resources page.

The “Export results” button on the search reports page will create individual CSV files for shortage reports and discontinuation reports containing data from the search results. Please note that the two CSV files will be downloaded in a single .zip file. Users would then need to open the .zip file to access the CSV files.

To search by product, please refer to the Search Product page.

A public access API (application program interface) is also available to access shortage and discontinuation report data in an alternative format. Access the API here.

The export is also available for download through an extract zip file that is updated monthly. Access the Monthly Report extract here.

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

To
Select from the options in the checkboxes/dropdown menu below to filter your results by report type.
Filter by reports that have been designated Tier 3 by Health Canada. Learn more
Select from the options in the checkboxes/dropdown menu below to filter your results by status type

Status Brand name Company Name Strength(s) Date Updated View Report
Avoided shortage PMS-BUPRENORPHINE-NALOXONE PHARMASCIENCE INC 2MG 0.5MG 2019-05-01 79878
Resolved TEVA-BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED 2MG 0.5MG 2022-12-02 167203
Resolved PMS-BUPRENORPHINE-NALOXONE PHARMASCIENCE INC 2MG 0.5MG 2017-11-23 2352
Resolved TEVA-BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED 2MG 0.5MG 2021-06-10 140363
Resolved MYLAN-BUPRENORPHINE/NALOXONE MYLAN PHARMACEUTICALS ULC 2MG 0.5MG 2017-04-12 3922
Actual shortage TEVA-BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED 2MG 0.5MG 2024-04-25 221534
Resolved ACT BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED 2MG 0.5MG 2020-01-24 95396
Resolved TEVA-BUPRENORPHINE/NALOXONE TEVA CANADA LIMITED 2MG 0.5MG 2021-06-03 139725
Resolved PMS-BUPRENORPHINE-NALOXONE PHARMASCIENCE INC 2MG 0.5MG 2019-07-03 86234
Resolved MYLAN-BUPRENORPHINE/NALOXONE MYLAN PHARMACEUTICALS ULC 2MG 0.5MG 2019-09-18 7392
Resolved TEVA-CYPROTERONE / ETHINYL ESTRADIOL TEVA CANADA LIMITED 2MG 0.035MG 2020-05-29 111857
Resolved THALLIUM LANTHEUS MI CANADA INC 2MCI 2019-05-11 81781
Discontinued THALLIUM LANTHEUS MI CANADA INC 2MCI 2023-10-25 161424
Actual shortage ONE-ALPHA CHEPLAPHARM ARZNEIMITTEL GMBH 2MCG 2024-01-22 213256
Resolved ONE-ALPHA CHEPLAPHARM ARZNEIMITTEL GMBH 2MCG 2019-04-22 60235
Resolved CALCITRIOL INJECTION USP STERIMAX INC 2MCG 2021-08-11 8288
Resolved ONE-ALPHA CHEPLAPHARM ARZNEIMITTEL GMBH 2MCG 2022-12-16 164812
Resolved ONE-ALPHA CHEPLAPHARM ARZNEIMITTEL GMBH 2MCG 2023-06-13 180961
Resolved CEFOXITIN FOR INJECTION TEVA CANADA LIMITED 2G 2021-10-07 146440
Resolved DEFEROXAMINE MESYLATE FOR INJECTION PFIZER CANADA ULC 2G 2020-05-26 110345

Showing 9601 to 9620 of 23394